The company’s shares were up about 9 percent at $21.09 on Wednesday on the New York Stock Exchange.Prior to Wednesday’s gains, the stock had lost about 12 percent of it value since March, when the U.S. Food and Drug Administration began an inspection of the company’s San Diego facility questioning t

http://wapo.st/K7vTBPWhat’s in a name? That’s a question that experts are wrestling with as they prepare to revise the diagnostic manual that spells out the criteria for addiction and other substance-use problems.The catalyst for this discussion is a set of proposed changes to the Diagnostic and Sta

(Reuters) – Alabama, one of two U.S. states that segregate inmates with HIV from the rest of their prison population, will seek to defend the policy against a class action lawsuit headed to trial in federal court on Monday.The American Civil Liberties Union sued Alabama in 2011 for what the group co

(Reuters) – Fewer people infected with HIV globally are dying as more of them get access to crucial antiretroviral drugs, particularly in sub-Saharan Africa, the United Nations AIDS program said on Wednesday.The United Nations estimates that about 34 million people are living with the human immunode

To learn how best to prescribe powerful drugs to children, Congress passed a law in the 1990s that rewarded drug makers for conducting clinical studies involving children. Among the incentives for cooperating companies was a possible six-month extension of protection from generic competition after a

PrePex, a bloodless circumcision device for adults, will be tested in at least nine African countries in the next year, according to the backers of the tests.The device, above, was approved by the Food and Drug Administration in January, and World Health Organization approval is expected soon. No su

Aiming at appropriate preparation for the future development of individualized and regenerative medicine (in particular, gene, stem cell and tissue engineering therapies), the Health Intervention and Technology Assessment (HITAP) program has agreed to conduct a study to provide an insight on elements necessary for national policymaking in Thailand.

Advanced health biotechnologies in Thailand: redefining policy directions. Román Pérez Velasco1*, Usa Chaikledkaew2,3, Chaw Yin Myint2 , Roongnapa Khampang2 , Sripen Tantivess2 and Yot Teerawattananon2* Abstract Background: Thailand faces a significant burden in terms of treating and managi

Antimicrobial Resistance (AMR) occurs when pathogens (bacteria, viruses, fungi, and parasites) develop a resistance or tolerance to the medicines that are used to combat these microorganisms, such that these treatments are no longer effective. AMR has been increasing in low-, middle- and high-income